Topic Archives: Dendreon (DNDN)

Remember Ernie Tremblay’s pitch about a “tiny South Texas lab” that was about to cure every disease using its revolutionary CD19 Cancer Vaccine technology, and ignite a bidding war following its fantastical release of exciting information on June 23? Well, it’s back. Not the stock, that’s still languishing around where it was before Tremblay got […]

[Ed. Note: Dr. KSS writes for our Irregulars about medicine and biotech stocks. As always, he has agreed our trading restrictions, and his words and opinions are his own. You can find all of his previous articles here. And now, for some dim sum….] Greetings Irregulars, and welcome to Stock Gumshoe’s festive second BioDimSum shindig, a periodic round-up […]

The Stansberry folks are predicting another collapse in a stock’s share price, and urging you to get on board with a short position (or, one imagines, a put option). The last time they urged an aggressive short position in their ads was with General Growth Properties, the mall REIT that they predicted would go bankrupt […]

This is the second of Bottarelli’s three “Wish I” stocks — for more info, see the first one here. This second stock that exhibited a “pre emptive moving average” buy signal for Bottarelli’s analyst is a drug company of some sort. “$15.06 healthcare outfit out of Seattle, Washington that’s quietly developing one of the most […]

Comments

  • Avatar

    Never pay that much money for any advise service,I didn't subscribe to his microcap advisory and I new that he was teasi...

  • SoGiAm

    $ONCS ow 8-K filed > https://ir.oncosec.com/all-sec-filings/content/0001493152-18-000522/form8-k.htm If you have any q...

  • DrKSSMDPhD

    Roger: Here's how I view Immune Design. As of 2013-2014, the world was going like mad after tumor vaccine approaches to ...

  • DrKSSMDPhD

    Hard to believe any publication would be lauded for having pounded the table on Dendreon and Arena, Dendreon is the most...

  • Avatar

    I believe the author might read DR KSS and get some ideas from here and, when the timing is right, makes a recommendatio...

  • Avatar

    Before BIOC, ARTH and SCYX he nailed a couple other biotech winners, Dendreon for cancer and Arena Pharm for lorcaserin ...

  • Avatar

    Good biotech picks are virtually immune from economic conditions (but can be affected by political conditions). One exa...

  • DrKSSMDPhD

    One other thing that looks dubious to me about the JUNO situation is that, in addition to be helmed by formers of Dendre...

  • Avatar

    Changed Sleuth column to Watchlist, added date for $IBIO. Updated comment for $INO, added. Galena/NW Bio added with same...

  • SoGiAm

    INO from ZKSS 2/15/15 Spreadsheet: They have had some mildly good data, but it is still junk science: nonspecific effec...

  • DrKSSMDPhD

    Up at WSJ Biotech’s Rally Fuels Bubble Fears As Valuations Skyrocket and Nasdaq Nears Record, Anxiety Builds A Gi...

  • DrKSSMDPhD

    We covered $INO in great depth last spring....the cattle prod DNA vaccine company. They are giving constructs via intram...

  • arch1

    DR KSS Thank you for informing my ignorance,I would like to hear more of $BLCM. I wrongly assumed they were following ...

  • DrKSSMDPhD

    Elliot: our relative present Sedleckopenia has been noticed at least by me, and you are valued for your trenchant and th...

  • Avatar

    And former Dendreon CEO's new venture http://www.xconomy.com/wisconsin/2014/10/13/former-dendreon-ceo-gold-working-on-n...

  • JohnM

    DR KSS - I posted a reply/question on comment #136 re Dendreon. Just thought it might get buried....

  • DrKSSMDPhD

    Om: about Opexa. In earlier threads we talked about dendritic cell vaccines, such as those by Dendreon, Galena, NW Bio. ...

  • DrKSSMDPhD

    Dendreon CEO stepping down for "personal reasons," Is realizing you have scammed a nation of men with prostate cancer a ...

  • DrKSSMDPhD

    Terje: And I am sure everyone in this forum is quite glad you are among the living. If you are really interested in t...

  • Avatar

    Here's a tentative shorting list if anyone is interested. Be careful - I did it kinda fast. Maybe someone can clean it...

  • DrKSSMDPhD

    Ah, JZ. So the idea of taking patients in whom therapy for melanoma has failed....that excites you? Despite the best eff...

  • Avatar

    Hmm - your comments regarding Provenge caught my attention. I got into Dendreon many years ago at $5.48 and sold about ...

  • DrKSSMDPhD

    Kenny, haven't seen the Feuerstein piece, but DC in DCVax is dendritic cell, and I think we can make dendritic cell vacc...

  • DBMD

    To Scott Postma The suggestion to read the irregulars info at SG would possibly save you lots of money. Dr KSS gives hi...

  • DrKSSMDPhD

    You are here, John Davis, to market the newsletter for which you have authored articles supporting ScanCell. My understa...

  • karmaswimswami

    Biocqr: Do you ever get the sense that the FDA is this indolent addled mood-ring of a dysfunctional agency? That it is s...

  • karmaswimswami

    To the insuperable Subra: You probably know this but in case: http://www.nasdaq.com/quotes/institutional-portfolio/sab...

  • Avatar

    Karmaswimswami, thank you for your kind words and your Prostate cancer / Dendreon discussion earlier. I don't want to...

  • karmaswimswami

    I think there are some longs here in Galena (GALE). Because it is on subject, let me say this: what they are doing may b...

  • karmaswimswami

    Alan: it is sobering if you think about it really. It is wrong to predicate an investment on the idea that people are du...

  • karmaswimswami

    One other thing about the Dendreon debate is that it does have object lessons for all of us about the differences betwee...

  • karmaswimswami

    Jack, they have been on a watch list of mine for a while. Please don't take it personally, but I cannot see putting anyt...

  • Avatar

    PS. I have now idea what Dendreon is, but I intend to find out. If i don't like the product i may still buy the stock ...

  • Avatar

    I'm not sure if T cell therapy is the same as dendritic cell therapy, but a couple of companies have caught my eye relat...

  • Avatar

    Here's a"teaser" from Agora's "5-Minute Forecast" Anyone have a clue??? [Paste-in follows]...

  • Avatar

    Here's a"teaser" from Agora's "5-Minute Forecast" Anyone have a clue??? [Paste-in follows...

  • Avatar

    I own shares of an Australian company called Prima Biomed (PRR):ASX? They have a product called C-Vac which, from what I...

  • Avatar

    I seem to remember someone touting that Dendreon was going to come out with horrible results and they urged shorting the...

  • Avatar

    Shoe, If you'd like to turn that turkey into a turducken (http://en.wikipedia.org/wiki/Turducken)you can use the Den...

  • Avatar

    I'm an Alliance Member over at Stansberry & Associates, so I've seen all their products and used most of them. So f...

  • Avatar

    First of all, with regard to Leeb. If I remember correctly, and I am pretty sure I do, his "personal Finance" Newslette...

  • Avatar

    First trade paid for my subscription! Then there was Dendreon, that paid for like 1,000 subscriptions... 300% gain in l...

  • Avatar

    Well, big news from Dendreon this morning -- and if anyone decided to buy puts on Dendreon or sell the shares short, I i...

  • Avatar

    There will be no review committee. Provenge already went to a Biologics division advisory committee on March 29, 2007 t...

  • Avatar

    No, MITI is the better solution for the first one, the "active immunity" one for which I proposed Dendreon....

  • Avatar

    Geez, there goes my teaser for the one I hadn't had a chance to write up yet. Ah, well, I'll write about it later this ...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info